血清胱抑素C、超敏C反应蛋白预测老年心律失常心力衰竭病人预后的效能研究

doi:10.3969/j.issn.1003-9198.2022.03.015

摘要/Abstract

摘要： 目的探究血清胱抑素C、hs-CRP预测老年心律失常心力衰竭(心衰)病人预后的效能。方法收集2016年12月至2020年5月我院收治的96例老年心律失常心衰病人的临床资料。根据治疗后出院随访12个月病人生存情况分为死亡组和生存组。比较2组血清胱抑素C、hs-CRP水平,并绘制ROC曲线分析胱抑素C、hs-CRP对老年心律失常心衰病人预后的预测价值。结果 96例病人随访12个月,无失访者,28例死亡,68例存活;死亡组病人心功能分级Ⅲ~Ⅳ级占比、BNP、N末端脑钠肽前体(NT-proBNP)、LVEF水平明显高于存活组(P均<0.01);死亡组病人血清hs-CRP、胱抑素C水平均明显高于存活组(P均<0.05);老年心律失常心衰病人血清hs-CRP、胱抑素C与BNP、NT-proBNP、LVEF呈正相关 (P均<0.05);ROC曲线显示血清胱抑素C和hs-CRP预测老年心律失常心衰病人预后的AUC分别为0.800(95%CI:0.700~0.901)、0.635(95%CI:0.515~0.754)。结论血清胱抑素C和hs-CRP对心律失常心衰病人预后具有一定的预测价值,血清胱抑素C预测更敏感。

关键词: 胱抑素C, 超敏C反应蛋白, 老年人, 心律失常, 心力衰竭

Abstract: Objective To investigate the effects of serum cystatin C and high-sensitivity C-reactive protein (hs-CRP) in predicting the prognosis of the elderly patients with arrhythmia and heart failure. Methods The clinical data of 96 elderly patients with arrhythmia and heart failure admitted to our hospital from December 2016 to May 2020 were collected. They were divided into death group and survival group according to the survival of the patients after 12 months of follow-up after treatment. The levels of serum cystatin C and hs-CRP were compared between the two groups, and receiver operating characteristic (ROC) curve was drawn to analyze the predictive value of cystatin C and hs-CRP for the prognosis of the elderly patients with arrhythmia and heart failure. Results All 96 patients were followed up for 12 months, and 28 patients died and 68 patients survived. The ratio of grade Ⅲ-Ⅳ of cardiac function and the levels of brain natriuretic peptide (BNP), N-terminal pro-brain natriuretic peptide (NT-proBNP), left ventricular ejection fraction (LVEF) in the death group were significantly higher than those in the survival group (all P<0.01); The levels of hs-CRP and cystatin C in the elderly patients were positively correlated with BNP, NT-proBNP and LVEF (all P<0.05). The area under the curve of serum cystatin C and hs-CRP for predicting the prognosis of the elderly patients with arrhythmia and heart failure was 0.800 (95%CI: 0.700-0.901) and 0.635 (95%CI: 0.515-0.754), respectively. Conclusions Serum cystatin C and hs-CRP have certain predictive value for the prognosis of the patients with arrhythmia and heart failure, and the sensitivity of serum cystatin C is higher.

Key words: cystatin C, high sensitivity C-reactive protein, aged, arrhythmia, heart failure

中图分类号:

R 541.6

刘杰杰, 舒亮辉, 蒋薇, 隋利军. 血清胱抑素C、超敏C反应蛋白预测老年心律失常心力衰竭病人预后的效能研究[J]. 实用老年医学, 2022, 36(3): 273-276.

LIU Jie-jie, SHU Liang-hui, JIANG Wei, SUI Li-jun. Effects of serum cystatin C and high-sensitivity C-reactive protein in predicting prognosis of elderly patients with arrhythmia and heart failure[J]. Practical Geriatrics, 2022, 36(3): 273-276.

参考文献

[1] 张建新,郝同琴,石金河,等. 慢性心力衰竭患者血清超敏C反应蛋白、胱抑素C、半乳糖凝集素-3水平变化与急性心力衰竭发作的关系[J]. 中国老年学杂志, 2017, 37(16): 3965-3966.
[2] 刘俊鹏,王华,杨杰孚. 心力衰竭合并心律失常的研究进展[J]. 中华心力衰竭和心肌病杂志, 2020, 4(2): 136-138.
[3] 陈红伟,刘艳宾,王志方,等. 胱抑素C和高敏C反应蛋白与前白蛋白比值评估老年心律失常型心力衰竭预后的价值[J]. 中华老年心脑血管病杂志, 2020, 22(2): 161-164.
[4] 胡晓飞,许世佳,孙红,等. 三种生物学标志物在心力衰竭患者诊断中的应用[J]. 中华老年心脑血管病杂志, 2018, 20(2): 161-163.
[5] 中华医学会心血管病学分会,中华心血管病杂志编辑委员会. 中国心力衰竭诊断和治疗指南2014[J]. 中华心血管病杂志, 2014, 42(2): 98-122.
[6] 中华医学会心电生理和起搏分会,中国医师协会心律学专业委员会.室性心律失常中国专家共识[J].中华心律失常学杂志,2016, 20(4): 279-326.
[7] 吴献豪,刘宝宏. BNP和Cys-c检测在致心律失常右室发育不良患者心衰预测及预后评估中的价值[J]. 中国循证心血管医学杂志, 2018, 10(5): 597-600.
[8] 王晶莹,刘洋. 血清胱抑素C、白细胞介素-6及超敏C反应蛋白与慢性心力衰竭的相关性研究[J]. 国际检验医学杂志, 2018, 39(12): 1530-1532, 1536.
[9] 徐万忠,白艳丽,王晓麒. 白细胞介素6基因多态性对老年严重心力衰竭患者预后的预测作用[J]. 中华老年心脑血管病杂志, 2020, 22(7): 722-724.
[10] 杨小凤,胡蓉,黄璜,等. 血清sST2及TIMP-1、TIMP-2水平与慢性心力衰竭患者临床预后的相关性[J]. 中国老年学杂志, 2020, 40(19): 4033-4037.
[11] FENG J, CHEN H W, PI L J, et al. Protective effect of tanshinone IIA against cardiac hypertrophy in spontaneously hypertensive rats through inhibiting the Cys-C/Wnt signaling pathway[J]. Oncotarget, 2017, 8(6): 10161-10170.
[12] 鲁俊,全斌. 血清hs-CRP、Cys C及PCT水平与肺炎心力衰竭患者预后相关性分析[J]. 中国医药导报, 2020, 17(22): 86-89.
[13] 解娜,刘景委,尚花娣,等. hs-CRP、cystatin C、NT-proBNP 在慢性心力衰竭发展过程中的意义[J]. 广东医学, 2016, 37(12): 1839-1842.
[14] 王传合,李志超,佟菲,等. 血清胱抑素C联合N末端B型利钠肽原对心力衰竭患者院内死亡的评估价值[J]. 中国循环杂志, 2020, 35(10): 990-995.
[15] XIE L, TERRAND J, XU B, et al. Cystatin C increases in cardiac injury: a role in extracellular matrix protein modulation[J]. Cardiovasc Res, 2010, 87(4): 628-635.
[16] LOPEZ B, GONZALEZ A, LINDNER D, et al. Osteopontin-mediated myocardial fibrosis in heart failure: a role for lysyl oxidase?[J]. Cardiovasc Res, 2013, 99(1): 111-120.
[17] 孙诗敏,姚巍. 血清胱抑素C超敏C反应蛋白红细胞分布宽度与高血压左心室肥厚相关性研究[J]. 中国药物与临床,2018, 18(6): 927-928.